Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus - Test2 - elhamkhani - TriplyDB

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

http://www.wikidata.org/entity/Q26700054

about

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic.Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus.

P2860

Q29994672-2674EE6D-D9F5-499D-8C63-D8D6E43AE98E Q30235533-FD9CFF65-9BB9-4D28-9683-2AA684E1032D Q39034541-5901B987-BB2E-4D44-8DDA-0F61083BD75C Q40317741-4DF9A5DB-DAB1-433A-A5A2-899554AD54C9 Q42330835-CCBE6BC1-F4F1-4D8C-8183-A7B75BF7BA02

P2860

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

http://www.wikidata.org/entity/Q26700054

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@ast

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@en

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@nl

type

label

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@ast

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@en

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@nl

prefLabel

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@ast

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@en

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@nl

P1433

Q26700054-F150AB5F-09EE-40EE-B1C6-BAC42D35AF60

P1476

Q26700054-98A74768-4E32-4CE7-BE2D-DD3577B3A410

P2093

Q26700054-098E3D29-ADA3-42C7-82E1-ADA7BB92B261

Q26700054-1685EBC2-1952-4064-AF48-B47454356E89

Q26700054-1C4642F5-9733-4E9A-ACAF-8BC3C4517F0B

Q26700054-20D56227-B44A-436C-8FB5-F0A411E9E82F

Q26700054-2E663D80-47E0-4B47-8E82-45DD1DA063A1

Q26700054-80479DA6-D74B-4787-A9E0-8B3AEDD726B1

Q26700054-971A9959-94AF-449A-B471-01A83AA9DF6B

Q26700054-A80B250E-4793-4610-882E-14E8063D6816

P2860

Q26700054-000FEEBE-D802-4C65-8514-22277EE1C69E

Q26700054-01B3A189-6912-4571-9097-7899AA8981DB

Q26700054-08FD447B-F00F-44A8-AD0D-0BDF3C950ADE

Q26700054-1383CB56-3FE5-4938-B740-CBD8AF7117C6

Q26700054-1AAA192E-0D93-4DB7-ADE0-A2358FB40E95

Q26700054-237B34A4-36E0-473E-8CDA-EF040D0A20EB

Q26700054-247847EE-D98C-48D2-B6F3-230CF9B36BD5

Q26700054-24AABF39-38F4-413B-9A6E-01EA2253604F

Q26700054-259B40E1-A388-4EF4-80C4-7337C8601B4B

Q26700054-3253E612-F527-4065-90FE-66896647A0DB

P31

Q26700054-57BAF042-8619-4E59-ACC8-CE453543B457

P3181

Q26700054-99A1EAE3-1DBE-46BD-AB8D-ED4E019B0916

P356

Q26700054-5D2B0F25-C250-4B61-B109-C56AEA0EEA35

P407

Q26700054-1E05BB27-FB93-4801-8819-07FF47019D31

P433

Q26700054-4E4F3A7A-5458-472B-B89A-BC25B0F4B355

P478

Q26700054-2D44B204-67DD-420A-B62C-424A389EFED0

P50

Q26700054-3EDF4E47-01C8-4195-BE78-486A3E891B95

P577

Q26700054-09619634-F34B-4324-A130-0BF045AAD1E2

P698

Q26700054-DDE7D135-05C8-4191-8CDC-44062CB9218F

P921

Q26700054-04D5BD7C-1324-47A7-8A71-75CF78B8D8C7

Q26700054-2E43CF7B-A819-4F15-938D-6232DA94F013

Q26700054-EFB4DF80-A4A0-47AA-9AB1-E3B2E551C774

P932

Q26700054-B43D3895-D75A-486E-90EA-B57FD90A5A73

P3181

P356

P1433

Emerging Infectious Diseases

P1476

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus

@en

P2093

Armen Donabedian

http://www.w3.org/2001/XMLSchema#string

Erik J Stemmy

http://www.w3.org/2001/XMLSchema#string

George Korch

http://www.w3.org/2001/XMLSchema#string

Jean Hu-Primmer

http://www.w3.org/2001/XMLSchema#string

Karl J Erlandson

http://www.w3.org/2001/XMLSchema#string

Michael O'Hara

http://www.w3.org/2001/XMLSchema#string

Michael Wathen

http://www.w3.org/2001/XMLSchema#string

Sally Hojvat

http://www.w3.org/2001/XMLSchema#string

P2860

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

SARS: systematic review of treatment effects

Anti-infective immunoadhesins from plants.

Animal models for SARS and MERS coronaviruses

Animal models of Middle East respiratory syndrome coronavirus infection

Rapid generation of a mouse model for Middle East respiratory syndrome.

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

P31

scholarly article

P3181

73835

http://www.w3.org/2001/XMLSchema#string

P356

10.3201/EID2207.160022

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Timothy M. Uyeki

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27191188

http://www.w3.org/2001/XMLSchema#string

P921

Middle East respiratory syndrome coronavirus

P932

4918159

http://www.w3.org/2001/XMLSchema#string